NL-OMON24025已完成不适用
A pilot study to test the feasibility, safety and efficacy of the addition of the BiTE antibody Blinatumomab to the Interfant-06 backbone in infants with MLL-rearranged acute lymphoblastic leukemia. A collaborative study of the Interfant network
Princess Maxima Center for Pediatric Oncology0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •In order to be eligible to participate in this study, a patient must meet all of the following criteria:
- •1. Patients must be treated according to Interfant-06 backbone
排除标准
- •A potential patient who meets any of the following criteria will be excluded from participation in this study:
- •1. Biphenotypic ALL
研究者
相似试验
进行中（未招募）
1 期
Blinatumomab in infant AAcute Lymphoblastic LeukemiaMedDRA version: 21.0Level: LLTClassification code 10000845Term: Acute lymphoblastic leukemiaSystem Organ Class: 100000004864EUCTR2016-004674-17-ATPrincess Máxima Center for Pediatric Oncology30
进行中（未招募）
1 期
Blinatumomab in infant AAcute Lymphoblastic LeukemiaEUCTR2016-004674-17-DEPrincess Máxima Center for Pediatric Oncology30
进行中（未招募）
1 期
Blinatumomab in infant acute lymphoblastic leukemia (ALL)Cancer - Children's - Leukaemia & LymphomaAcute Lymphoblastic LeukemiaACTRN12620000542998Princess Máxima Center for Pediatric Oncology30
进行中（未招募）
1 期
Blinatumomab in infant AAcute Lymphoblastic LeukemiaEUCTR2016-004674-17-NLPrincess Máxima Center for Pediatric Oncology30
进行中（未招募）
1 期
Blinatumomab in infant AAcute Lymphoblastic LeukemiaMedDRA version: 21.0Level: LLTClassification code 10000845Term: Acute lymphoblastic leukemiaSystem Organ Class: 100000004864EUCTR2016-004674-17-CZPrincess Máxima Center for Pediatric Oncology30